TY  - GEN
AU  - Mayer-Hamblett,Nicole
AU  - Retsch-Bogart,George
AU  - Kloster,Margaret
AU  - Accurso,Frank
AU  - Rosenfeld,Margaret
AU  - Albers,Gary
AU  - Black,Philip
AU  - Brown,Perry
AU  - Cairns,AnneMarie
AU  - Davis,Stephanie D
AU  - Graff,Gavin R
AU  - Kerby,Gwendolyn S
AU  - Orenstein,David
AU  - Buckingham,Rachael
AU  - Ramsey,Bonnie W
TI  - Azithromycin for Early Pseudomonas Infection in Cystic Fibrosis. The OPTIMIZE Randomized Trial
SN  - 1535-4970
PY  - 2019///0923
KW  - Administration, Inhalation
KW  - Adolescent
KW  - Anti-Bacterial Agents
KW  - therapeutic use
KW  - Azithromycin
KW  - Child
KW  - Child, Preschool
KW  - Cystic Fibrosis
KW  - complications
KW  - Double-Blind Method
KW  - Drug Therapy, Combination
KW  - methods
KW  - Female
KW  - Humans
KW  - Infant
KW  - Male
KW  - Pseudomonas Infections
KW  - Pseudomonas aeruginosa
KW  - drug effects
KW  - Recurrence
KW  - Time Factors
KW  - Tobramycin
KW  - administration & dosage
KW  - Treatment Outcome
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, N.I.H., Extramural
UR  - https://doi.org/10.1164/rccm.201802-0215OC
ER  -